Bosentan Monohydrate

Especificaciones

157212-55-0Número CAS

620-486-3Número CE

4-tert-butyl-N-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2-pyrimidin-2-ylpyrimidin-4-yl]benzenesulfonamide;hydrateNombre IUPAC

C27H31N5O7SFórmula química

569.6 g/molPeso molecular

Bosentan hydrate; 157212-55-0; bosentan monohydrate; DTXSID80873178; 4-tert-butyl-N-(6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2,2'-bipyrimidin-4-yl)benzenesulfonamide hydrate; CHEBI:31300; 4-tert-butyl-N-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2,2'-bipyrimidin-4-yl]benzenesulfonamide hydrate; RefChem:526848; DTXCID90820678; 4-(tert-Butyl)-N-(6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-[2,2'-bipyrimidin]-4-yl)benzenesulfonamide hydrate; Bosentan (hydrate); MFCD09751188; Bosentan [USAN]; 4-tert-butyl-N-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2-pyrimidin-2-ylpyrimidin-4-yl]benzenesulfonamide;hydrate; Benzenesulfonamide, 4-(1,1-dimethylethyl)-N-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)[2,2'-bipyrimidin]-4-yl]-, hydrate (1:1); Bosentan (USAN); Bosentan [USAN:INN:BAN]; Bosentan hydrate (JAN); Benzenesulfonamide, 4-(1,1-dimethylethyl)-N-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)[2,2'-bipyrimidin]-4-yl]-, hydrate(1:1); BOSENTAN HYDRATE [JAN]; p-tert-Butyl-N-(6-(2-hydroxyethoxy)-5-(o-methoxyphenoxy)-2-(2-pyrimidinyl)-4-pyrimidinyl)benzenesulfonamide monohydrate; Actelion; C27H31N5O7S; UNII-Q326023R30; Tracleer (TN); Benzenesulfonamide, 4-(1,1-dimethylethyl)-N-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)[2,2'-bipyrimidin]-4-yl]-, hydrate (1:1); Benzenesulfonamide, 4-(1,1-dimethylethyl)-N-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)[2,2'-bipyrimidin]-4-yl]-, monohydrate (9CI); Bosentan hydrate; Bosentan monohydrate; 4-(tert-Butyl)-N-(6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-[2,2'-bipyrimidin]-4-yl)benzenesulfonamid; BOSENTAN [VANDF]; BOSENTAN [USP-RS]; MLS004774049; SCHEMBL617167; Tracleer, Bosentan monohydrate; Bosentan (hydrate) (Standard); BOSENTAN [ORANGE BOOK]; HY-A0013AR; orb1300923; SCHEMBL29620398; HY-A0013A; BOSENTAN MONOHYDRATE [MI]; SXTRWVVIEPWAKM-UHFFFAOYSA-N; GLXC-05078; HMS3651P16; HMS5081C10; CS-M0881; Bosentan hydrate, >=98% (HPLC); EBC-72036; s3051; BOSENTAN MONOHYDRATE [WHO-DD]; AKOS015897290; AC-4265; BOSENTAN MONOHYDRATE [EMA EPAR]; CCG-270091; CS-1265; FB19001; FB32083; KS-1231; SB17357; 4-tert-butyl-N-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2-pyrimidin-2-yl-pyrimidin-4-yl]benzenesulfonamide hydrate; DA-51349; SMR003500718; SY097059; DB-229208; SW199648-2; T6265; D01227; F093449; Q27114267; 4-(1,1-dimethylethyl)-n-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)[2,2'-bipyrimidin]-4-yl]benzenesulfonamide; 4-(tert-Butyl)-N-(6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-[2,2`-bipyrimidin]-4-yl)benzenesulfonamide hydrate; 4-Tert-butyl-N-(6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2,2-bipyrimidin-4-yl)benzenesulfonamide hydrate; 4-tert-butyl-N-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)- 2-(pyrimidin-2-yl)pyrimidin-4-yl]benzene-1-sulfonamide monohydrate; 4-tert-Butyl-N-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2-(pyrimidin-2-yl)pyrimidin-4-yl]benzenesulfonamide monohydrate; 4-tert-butyl-N-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2-pyrimidin-2-yl-pyrimidin-4-yl]benzenesulfonamide;hydrate; 4-tert-Butyl-N-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)[2,2'-bipyrimidin]-4-yl]benzene-1-sulfonamide--water (1/1); Benzenesulfonamide, 4-(1,1-dimethylethyl)-N-(6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)(2,2'-bipyrimidin)-4-yl)-, monohydrate; BENZENESULFONAMIDE, 4-(1,1-DIMETHYLETHYL)-N-(6-(2-HYDROXYETHOXY)-5-(2-METHOXYPHENOXY)(2,2'BIPYRIMIDIN)-4-YL)-, MONOHYDRATE; p-tert-Butyl-N-[6-(2-hyd roxyethoxy)-5-(o-methoxyphenoxy)-2-(2-pyrimidinyl)-4-pyrimidinyl]benzenesulfonamideSinónimos